<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03903731</url>
  </required_header>
  <id_info>
    <org_study_id>16-4049-08B</org_study_id>
    <nct_id>NCT03903731</nct_id>
  </id_info>
  <brief_title>Safety and Performance of Journey II BCS Total Knee System Patient Reported Outcome Measures</brief_title>
  <acronym>JIIPROMS</acronym>
  <official_title>Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter Study. Patient Reported Outcomes Measures</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Smith &amp; Nephew, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Smith &amp; Nephew, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Safety and Performance of Journey II BCS Total Knee System. A Retrospective, Multicenter
      Study. Patient Reported Outcome Measures.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 19, 2018</start_date>
  <completion_date type="Actual">June 28, 2019</completion_date>
  <primary_completion_date type="Actual">June 28, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Revision of one or more study device components</measure>
    <time_frame>12 Weeks</time_frame>
    <description>We are measuring the number of revision cases</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse Events</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>Number of adverse events reported per ISO 14155 guidelines</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization: Hospitalization</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>Length of hospital stay for primary (index) surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization: Hospitalization</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>Number of hospitalizations (admission for inpatient care) occurring after the hospitalization for the index surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization: Hospitalization</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>Length of stay for hospitalizations (admission for inpatient care) occurring after the hospitalization for the index surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization: Rehabilitation</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>number of sessions and duration of rehabilitation in weeks</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization: Outpatient visits</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>Number of outpatient visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health care utilization: Outpatient visits</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>Type of outpatient visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health Care Utilization: Re-operations</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>number of re-operations and revisions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient reported outcome implantation</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>EQ-5D-3L - Change in quality of life from baseline to one year postoperatively by answering quality of life questions on a 1-5 scale with 1 representing &quot;never&quot; and 5 representing &quot;always&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcomes</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>Knee Society Score - This validated tool combines an objective physician-derived component with a subjective subject-derived component. The objective section rates alignment, instability, joint motion and symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to Work</measure>
    <time_frame>implantation through study completion, approximately 8 years</time_frame>
    <description>Changes in employment status will be recorded with the date on which the change occurred and the change status.</description>
  </secondary_outcome>
  <enrollment type="Actual">554</enrollment>
  <condition>Journey II BCS Total Knee System</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Total knee arthroplasty with Journey II BCS Total Knee System</intervention_name>
    <description>Journey II BCS Total Knee System</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects who received the Journey II BCS Total Knee System
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject received primary uni- or bi-lateral total knee arthroplasty with the Journey
             II BCS Total Knee System for approved indication;

          -  The TKA occurred at least 12 weeks prior to enrollment

          -  Subject records contain Patient Reported Outcome data obtained ≤3 months prior to as
             well as ≥6 months post-enrollment.

        Exclusion Criteria:

          -  Subject received the JOURNEY II BCS Total Knee System on the affected knee as a
             revision for a previously failed total or unicondylar knee arthroplasty
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra Navarrete</last_name>
    <role>Study Chair</role>
    <affiliation>Smith &amp; Nephew, Inc.</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael R. Dayton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Orthopaedics, University of Colorado Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David J. Mayman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Harold E. Cates, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tennessee Orthopaedic Clinics</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hilde Vandenneucker, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>UZ Leuven</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter Black, MBBCh</last_name>
    <role>Principal Investigator</role>
    <affiliation>Anglesea Clinic Orthopaedics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Orthopaedics, University of Colorado Denver</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tennessee Orthopaedic Clinics</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37922</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Anglesea Clinic Orthopaedics</name>
      <address>
        <city>Hamilton</city>
        <zip>3204</zip>
        <country>New Zealand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>New Zealand</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>March 26, 2019</study_first_submitted>
  <study_first_submitted_qc>April 2, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2019</study_first_posted>
  <last_update_submitted>May 1, 2020</last_update_submitted>
  <last_update_submitted_qc>May 1, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

